NCT04945005View on ClinicalTrials.gov

Prevention of Pacemaker Lead Induced Tricuspid regurgitAtion by Transesophageal eCho guidEd Implantation Registry

CompletedOBSERVATIONAL
Enrollment

124

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Tricuspid Valve InsufficiencyPacemaker ComplicationEchocardiography, Transesophageal
Interventions
PROCEDURE

Transesophageal guidance of lead implantation

In patients undergoing lead implantation including transesophageal echocardiography for clinical reasons (e.g. intraprocedural cardioversion), echocardiography was also used for guidance of lead implantation to reduce lead-leaflet interactions

Trial Locations (1)

81377

LMU Klinikum, Munich

All Listed Sponsors
lead

LMU Klinikum

OTHER

NCT04945005 - Prevention of Pacemaker Lead Induced Tricuspid regurgitAtion by Transesophageal eCho guidEd Implantation Registry | Biotech Hunter | Biotech Hunter